Clinical Trials Directory

Trials / Completed

CompletedNCT03488719

A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate

A Phase 1 Study to Examine Pharmacodynamic Interaction Between Tesofensine and Metoprolol on 24-hours Mean Heart Rate

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Saniona · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

A Phase 1 Study to Examine Pharmacodynamic Interaction Between Tesofensine and Metoprolol on 24-hours Mean Heart Rate

Detailed description

In this study, the dose-response relationship between tesofensine and metoprolol will be examined and thus the optimal dose of metoprolol to mitigate the effects of tesofensine on heart rate (HR) will be determined. HR is the primary endpoint because in the previous studies it has been shown to be the most affected safety endpoint by the effects of tesofensine. After enrolment of 37 subjects, 2 Subjects (0115 and 0147) in dose cohort 2 experienced prolonged tachycardia (\> 120 beats per minute (bpm) lasting for 30 min) documented in Holter Electrocardiogram (ECG) recording (a stopping criteria of the study). Therefore, the study was temporarily halted on 22 November 2018. Subsequent to the temporary halt, Saniona reviewed all the available data in January and February 2019 and determined that the results obtained from the completed participants were sufficiently robust to answer the questions for which the trial was designed. Therefore, Saniona decided to permanently end the trial on 20 February 2019.

Conditions

Interventions

TypeNameDescription
DRUGMetoprolol Succinate 25 MGA single dose of 25 mg metoprolol ER in the morning of Day 15, Day 18 or Day 21 approximately 30 minutes after start of a standard breakfast and together with the tesofensine dose.
DRUGMetoprolol Succinate 50 MGA single dose of 50 mg metoprolol ER in the morning of Day 15, Day 18 or Day 21 approximately 30 minutes after start of a standard breakfast and together with the tesofensine dose.
DRUGMetoprolol Succinate 100 MGA single dose of 100 mg metoprolol ER in the morning of Day 15, Day 18 or Day 21, approximately 30 minutes after start of a standard breakfast and together with the tesofensine dose.

Timeline

Start date
2018-07-11
Primary completion
2019-06-06
Completion
2019-06-06
First posted
2018-04-05
Last updated
2024-02-09
Results posted
2024-02-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03488719. Inclusion in this directory is not an endorsement.